Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2025 09:43 ET | Source: Research and Markets

Daratumumab or Darzalex Market Research Report 2025: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2019-2024, 2024-2029F, 2034F

Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Daratumumab or Darzalex Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ...
May 09, 2025 06:45 ET | Source: Research and Markets

Stelara (Ustekinumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2024, 2024-2029F, 2034F

Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Stelara (Ustekinumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ...
May 08, 2025 05:28 ET | Source: Research and Markets

CDK9 Inhibitor Pipeline Insight Report 2025: In-Depth Insights Into 15+ Companies and 15+ Drugs in the CDK9 Inhibitor Pipeline, Including Dinaciclib, KB-0742, and Alvocidib

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "CDK9 Inhibitor - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. The "Cyclin-Dependent Kinase 9 (CDK9) Inhibitor...
May 08, 2025 04:32 ET | Source: Research and Markets

Coronavirus (COVID-19) Current Therapy Market Opportunities and Strategy Report 2025: Strategic Investments, Digital Innovation, and Emerging Market Expansion Key to Growth

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Coronavirus (COVID-19) Current Therapy Market Opportunities and Strategies to 2034" report has been added to ResearchAndMarkets.com's offering.This...
May 08, 2025 04:23 ET | Source: Research and Markets

Rituxan Hycela, Rituxan Mabthera (Rituximab) Market Research Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2034

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Rituxan Hycela, Rituxan Mabthera (Rituximab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added...
May 08, 2025 04:19 ET | Source: Research and Markets

Tysabri (natalizumab) Market Research Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2034

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Tysabri (natalizumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ...
May 08, 2025 04:18 ET | Source: Research and Markets

Tecentriq (Atezolizumab) Market Research Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2034

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Tecentriq (Atezolizumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ...
April 30, 2025 13:39 ET | Source: Spherix Global Insights

Specialists Eye Gazyva as a New Option for Lupus Nephritis, but ACR Guidelines Favor Benlysta and Lupkynis for Upfront Use, According to Spherix Global Insights

EXTON, PA, April 30, 2025 (GLOBE NEWSWIRE) -- The American College of Rheumatology’s (ACR) newly updated treatment guidelines for lupus nephritis (LN) have led specialists to reconsider their...
April 30, 2025 04:49 ET | Source: Research and Markets

Darzalex Faspro Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Darzalex Faspro Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ...
April 14, 2025 07:00 ET | Source: SynOx Therapeutics Limited

SynOx Therapeutics Receives Fast Track Designation from U.S. Food and Drug Administration for Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT)

DUBLIN, Ireland and OXFORD, United Kingdom, April 14, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for...

Next Page keyboard_arrow_right